Charter Oak Capital Management’s Novo Nordisk NVO Stock Holding History

Charter Oak Capital Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-140	Closed	-$3K	–	629
2022 Q2	$3K	Hold	140	–	–	﹤0.01%	795
2022 Q1	$3K	Hold	140	–	–	﹤0.01%	839
2021 Q4	$3K	Hold	140	–	–	﹤0.01%	747
2021 Q3	$3K	Hold	140	–	–	﹤0.01%	728
2021 Q2	$3K	Hold	140	–	–	﹤0.01%	718
2021 Q1	$3K	Hold	140	–	–	﹤0.01%	684
2020 Q4	$3K	Buy	+140	New	+$4.84K	﹤0.01%	646

Other funds holding NVO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Charter Oak Capital Management's NVO Position: Q3 2022 in Review

Charter Oak Capital Management sold out of Novo Nordisk (NVO) in Q3 2022, closing a stake of 140 shares — an estimated $3K sold.

Charter Oak Capital Management first reported a position in NVO in Q4 2020 and held it in 7 quarters. The position peaked at $3K in Q2 2022. 907 funds tracked by Wall St. Rank hold NVO as of Q3 2022.

Charter Oak Capital Management reported no remaining Novo Nordisk position as of Q3 2022 after selling out during the quarter.
Charter Oak Capital Management sold 140 Novo Nordisk shares in Q3 2022, an estimated $3K.
Charter Oak Capital Management first reported a position in Novo Nordisk in Q4 2020 and held it in 7 quarters.
Charter Oak Capital Management's Novo Nordisk position peaked at $3K in Q2 2022.
907 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2022.

Based on Charter Oak Capital Management's 13F filing for Q3 2022, filed 6 Dec 2022.